Unlocking Health Insights: Predictive Value of RRI and β2-MG in Patient Outcomes
- Urosepsis is a serious condition that arises from an infection in the urinary tract.
- Among the complications of urosepsis, acute kidney injury (AKI) is common and severe.
- Recent research suggests that urinary biomarkers may offer a more timely diagnosis of AKI.
Introduction to Urosepsis and Acute Kidney Injury
Table of Contents
Urosepsis is a serious condition that arises from an infection in the urinary tract. It can lead to life-threatening organ dysfunction. Recent guidelines now require a Sequential Organ Failure Assessment (SOFA) score of 2 or more, in addition to evidence of urinary tract infection (UTI), for a diagnosis of urosepsis. This condition accounts for 9% to 31% of sepsis cases and is often caused by infections affecting the urinary system.
Among the complications of urosepsis, acute kidney injury (AKI) is common and severe. Studies show that patients with sepsis-associated AKI (S-AKI) have a mortality rate 6-8 times higher than those without AKI. Effective early diagnosis and treatment are crucial for improving outcomes. Traditional methods for detecting AKI rely on serum creatinine levels and urine output. However, these methods can delay diagnosis and may not always be reliable.
Recent research suggests that urinary biomarkers may offer a more timely diagnosis of AKI. One promising biomarker is β2-microglobulin (β2-MG). This protein is produced by all nucleated cells and is usually filtered by functioning kidneys. Elevated levels of β2-MG can indicate early renal impairment before serum creatinine levels change significantly.
Clinical Data and Methods
This study focused on patients diagnosed with urosepsis at Tongji Hospital from January 2022 to December 2023. It used a prospective observational design and collected data from the hospital’s Case Management System.
Inclusion Criteria:
- Hospitalization for over 24 hours
- Meeting diagnostic criteria for urosepsis
- Complete clinical data
- Signed informed consent
Exclusion Criteria:
- Patients under 18 years
- Hospital stays under 24 hours
- Specific cardiac or autoimmune conditions.
The study recorded details on patient demographics, vital signs, and various lab parameters within 24 hours of admission. This included measurements for hemoglobin, white blood cell count, procalcitonin, and more.
Renal Artery Resistive Index (RRI) Measurement:
An intensivist performed RRI measurements within 6 hours of admission using Doppler ultrasound. This method identifies blood flow in the kidneys and helps evaluate renal function.
Results
A total of 121 urosepsis patients were screened, with 108 meeting inclusion criteria. Of these, 67 developed AKI. Significant differences between the AKI group and the non-AKI group were noted in factors such as serum creatinine, RRI, and β2-MG levels.
Logistic Regression Analysis:
The analysis identified RRI, β2-MG, and procalcitonin as independent predictors of AKI. A receiver operating characteristic (ROC) curve analysis further demonstrated the predictive abilities of these variables.
Clinical Prediction Model:
A nomogram was developed to predict AKI risk in urosepsis patients. This model demonstrated high predictive value and calibration, making it a potential clinical tool.
Conclusion
This study found that higher levels of RRI, β2-MG, and procalcitonin are strong indicators of AKI in urosepsis patients. The combination of RRI and β2-MG enhances predictive capabilities compared to using individual measures. A validated nomogram based on these predictors shows promise for improving early AKI detection and patient outcomes.
Acknowledgments
We thank all staff members who contributed to this research, and we recognize the support from various funding programs.
Ethics Approval
The study followed the Declaration of Helsinki guidelines and received ethical review approval from Shanghai Tongji Hospital. Informed consent was obtained from all patients or their guardians.
References
[Omitted for brevity]